# Claude Opus 5.5 (low): Assess Settlement Value Range for Product Liability Crush Injury Case — Litigation Settlement Memorandum

> [!NOTE]
> **Unedited model output and AI judge grades.** The deliverables are AI-generated drafts on Harvey LAB's fictional task records. Pass/fail verdicts are the native LAB judges' AI judgments, not human review or accepted corrections. See the [model-runs overview](../../README.md).

[Task audit page](../../../tasks/assess-settlement-value-range/README.md) · [Pinned task and rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json) · [GPT-6 Luna (xhigh) run](../gpt6luna-xhigh/README.md) · [All runs](../../README.md)

**Model:** `claude-opus-5-5`, reasoning effort `low`. **Run:** `20260926-202411`.

**Native grades:** Sonnet 4.6 passed 47 of 52 criteria; GPT-5.5 passed 49 of 52 criteria. LAB all-pass score: 0 (mean of the judges' all-pass results; a task scores 1 with a judge only if every criterion passes).

## Deliverables

- [settlement-valuation-memo.docx](output/settlement-valuation-memo.docx) ([read as Markdown](output/settlement-valuation-memo.docx.md))

## Grades

Failures are in bold. Each criterion links to both judges' reasoning below.

| Criterion | Title | Sonnet 4.6 | GPT-5.5 |
|---|---|---|---|
| [C-001](#c-001) | References October 2019 internal engineering emails as significant evidence | Pass | Pass |
| [C-002](#c-002) | Identifies Reedley and Mitchum as authors of internal emails | Pass | Pass |
| [C-003](#c-003) | Emails show Greenfield had internal knowledge of re-cycling defect | Pass | Pass |
| [C-004](#c-004) | Emails show redundant interlock was rejected on cost grounds | Pass | Pass |
| [C-005](#c-005) | Connects internal emails to punitive damages exposure | Pass | Pass |
| [C-006](#c-006) | References 7 prior field reports as compounding punitive risk | Pass | Pass |
| [C-007](#c-007) | Factors punitive damages into settlement range despite Ohio cap | Pass | Pass |
| [C-008](#c-008) | Identifies Ohio non-economic damages cap under O.R.C. § 2315.18 | Pass | Pass |
| [C-009](#c-009) | Identifies cap exception for amputation under O.R.C. § 2315.18(B)(3) | Pass | Pass |
| [C-010](#c-010) | Recognizes full non-economic damages claim is viable | Pass | Pass |
| [C-011](#c-011) | Addresses workers' comp subrogation lien amount | Pass | Pass |
| [C-012](#c-012) | Analyzes lien's impact on plaintiff's net recovery and settlement dynamics | Pass | Pass |
| [C-013](#c-013) | Analyzes Apex's guard modification as comparative fault factor | Pass | Pass |
| [C-014](#c-014) | Recognizes re-cycling defect exists independently of guard modification | Pass | Pass |
| [C-015](#c-015) | Provides fault allocation percentage or range for Greenfield | Pass | Pass |
| [C-016](#c-016) | Provides fault allocation percentage or range for Apex | Pass | Pass |
| [C-017](#c-017) | Provides fault allocation percentage or range for Holt | Pass | Pass |
| [C-018](#c-018) | References Ohio's modified comparative fault system | **Fail** | **Fail** |
| [C-019](#c-019) | Applies fault allocated to non-party Apex as reducing plaintiff's recovery | Pass | Pass |
| [C-020](#c-020) | Identifies litigation reserve of $3.2M as inadequate and recommends increase | Pass | Pass |
| [C-021](#c-021) | Recommends specific updated reserve amount | Pass | Pass |
| [C-022](#c-022) | Discusses post-incident interlock addition as litigation risk | Pass | Pass |
| [C-023](#c-023) | References FRE 407 and its exceptions regarding post-incident remedial measure | Pass | Pass |
| [C-024](#c-024) | Identifies Daubert risk to defense expert Dr. Kwan | Pass | Pass |
| [C-025](#c-025) | Identifies analytical gap in Dr. Kwan's opinion regarding independent re-cycling defect | Pass | Pass |
| [C-026](#c-026) | Compares Dr. Aldrich's and Dr. Cho's economic damages figures | Pass | Pass |
| [C-027](#c-027) | Identifies specific disputed assumptions between economists | Pass | Pass |
| [C-028](#c-028) | Analyzes which economic assumptions are more defensible | Pass | Pass |
| [C-029](#c-029) | Arrives at a 'most probable' economic damages figure | Pass | Pass |
| [C-030](#c-030) | Addresses Halcyon contract as practical settlement pressure | Pass | Pass |
| [C-031](#c-031) | Identifies loss of consortium as separate damages element | Pass | Pass |
| [C-032](#c-032) | Analyzes loss of consortium under Ohio law | **Fail** | **Fail** |
| [C-033](#c-033) | Identifies potential contribution/indemnity claim against Apex | Pass | Pass |
| [C-034](#c-034) | Notes settlement does not extinguish contribution rights against Apex | **Fail** | **Fail** |
| [C-035](#c-035) | Identifies Garza v. Titan Hydraulics as most analogous comparable | Pass | Pass |
| [C-036](#c-036) | Identifies Novak v. Steelform Industries as most analogous comparable | **Fail** | Pass |
| [C-037](#c-037) | Discusses adjustments to comparables for factual differences | Pass | Pass |
| [C-038](#c-038) | Provides settlement range with low/mid/high values | Pass | Pass |
| [C-039](#c-039) | Settlement range falls within reasonable bounds ($4M–$8.5M) | Pass | Pass |
| [C-040](#c-040) | Provides recommended opening offer for mediation | Pass | Pass |
| [C-041](#c-041) | Assesses insurance coverage adequacy | Pass | Pass |
| [C-042](#c-042) | Notes settlement likely within primary policy limits | Pass | Pass |
| [C-043](#c-043) | References plaintiff's settlement demand of $9.5M | Pass | Pass |
| [C-044](#c-044) | References defense's proposed range of $1.8M–$2.5M | Pass | Pass |
| [C-045](#c-045) | Correctly states plaintiff's total economic damages per Dr. Aldrich | Pass | Pass |
| [C-046](#c-046) | Correctly states defense total economic damages per Dr. Cho | Pass | Pass |
| [C-047](#c-047) | References June 9, 2025 trial date as relevant timing factor | Pass | Pass |
| [C-048](#c-048) | Discusses plaintiff's counsel's track record as risk factor | Pass | Pass |
| [C-049](#c-049) | Correctly describes Holt's injury as below-elbow amputation | Pass | Pass |
| [C-050](#c-050) | Addresses Brewer defense verdict as limiting comparable | Pass | Pass |
| [C-051](#c-051) | Discusses SIR exhaustion by defense costs | Pass | Pass |
| [C-052](#c-052) | Holt's 78% whole-person permanent impairment rating referenced | **Fail** | Pass |

## Judge reasoning

### C-001

References October 2019 internal engineering emails as significant evidence ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L19))

- **Sonnet 4.6: Pass.** The memo extensively references the October 2019 internal engineering emails throughout multiple sections. In Section I (Bottom Line), it states the 'October 2019 Reedley/Mitchum emails make a majority-fault finding against Greenfield more likely than not and put punitive damages squarely before the jury.' In Section I corrections, it references GF-DOC-004471--73, -004476--78, and GF-DOC-004479 specifically. In Section III.A, it discusses Reedley's Oct. 7 and Oct. 11, 2019 emails as admissions that the design 'does not meet' ANSI standards and predicts 'a crush amputation.' The memo characterizes these emails as highly damaging, noting they 'directly contradict' defense arguments and that 'a jury will read these as admissions by Greenfield's own engineer.' The memo clearly identifies these emails as significant and damaging evidence for the defense, satisfying the criterion.
- **GPT-5.5: Pass.** The memo repeatedly identifies the October 2019 Reedley/Mitchum internal engineering emails, including GF-DOC-004471--73 and GF-DOC-004476--79, as significant damaging evidence: it says they make majority fault and punitive damages likely, contain internal admissions that the design did not meet ANSI requirements, predicted a crush amputation, recommended a low-cost fix, and undermine defense positions.

### C-002

Identifies Reedley and Mitchum as authors of internal emails ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L27))

- **Sonnet 4.6: Pass.** The memo repeatedly references Reedley and Mitchum by name as the authors/participants of the October 2019 internal emails. For example, it mentions 'Reedley's Oct. 7 and Oct. 11, 2019 emails,' 'Mitchum's Oct. 9, 2019 email,' 'Reedley/Mitchum emails,' and discusses their specific statements and actions. The criterion requires identification of these two individuals as authors/participants of the October 2019 internal engineering emails, which the memo clearly satisfies.
- **GPT-5.5: Pass.** The memo expressly refers to the October 2019 internal emails as the “Reedley/Mitchum emails,” describes “Reedley’s Oct. 7 and Oct. 11, 2019 emails,” and “Mitchum’s Oct. 9, 2019 email,” thereby identifying Reedley and Mitchum as the relevant authors/participants.

### C-003

Emails show Greenfield had internal knowledge of re-cycling defect ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L35))

- **Sonnet 4.6: Pass.** The memo extensively describes the content of the internal engineering emails (specifically the October 2019 Reedley/Mitchum emails) and their relevance to Greenfield's internal knowledge of the re-cycling defect. It states that Reedley's emails say the single-valve architecture 'does not meet' ANSI B11.2-2013 control-reliability requirements, that he predicted 'a crush amputation,' and that Mitchum deferred the fix despite knowing of prior injury reports. The memo explicitly connects these emails to Greenfield's internal knowledge of the defect, noting they 'make a majority-fault finding against Greenfield more likely than not and put punitive damages squarely before the jury.' This clearly satisfies the criterion.
- **GPT-5.5: Pass.** The memo expressly describes the October 2019 Reedley/Mitchum internal engineering emails as showing Greenfield knew of the re-cycling/control-reliability defect, prior field reports and injuries, Reedley’s recommendation for a fix and warning of a crush amputation, and Mitchum’s decision to defer the fix/risk assessment. This satisfies the criterion.

### C-004

Emails show redundant interlock was rejected on cost grounds ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L43))

- **Sonnet 4.6: Pass.** The memo explicitly states in Section II (Case Snapshot) under 'Prior notice': 'Reedley's Oct. 2019 recommendation: $385/unit, 6 weeks, plus a field retrofit bulletin. Deferred to the "Phase 2" refresh.' It also states in Section V.A: 'Mitchum declined a risk assessment and deferred the $385 fix mainly for budget-cycle and delivery reasons.' This clearly describes the recommended redundant interlock fix being deferred/rejected on cost/budget grounds at $385/unit.
- **GPT-5.5: Pass.** The memo explicitly states that Reedley recommended a fix costing about $385/unit plus a retrofit bulletin, that it was deferred to the Phase 2 refresh, and later notes Mitchum deferred the $385 fix mainly for budget-cycle and delivery reasons. This describes the recommended redundant/interlock fix being deferred on cost-related grounds.

### C-005

Connects internal emails to punitive damages exposure ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L51))

- **Sonnet 4.6: Pass.** The memo explicitly connects the internal engineering emails to punitive damages exposure under Ohio law. In Section V.A, the memo states the standard for punitive damages requires 'flagrant or conscious disregard for the safety of persons likely to be harmed (R.C. 2315.21; R.C. 2307.80)' and then directly links the Reedley/Mitchum emails to this standard: Reedley predicted 'a crush amputation,' Mitchum deferred the fix despite knowing of injury reports, and Mitchum declined a risk assessment and deferred the $385 fix 'mainly for budget-cycle and delivery reasons.' The memo also references these emails in Section I as making 'punitive damages squarely before the jury' and notes the emails show 'conscious disregard.' The connection between the internal emails (knowledge of defect, cost-based deferral) and the punitive damages standard under R.C. 2315.21 is explicit and direct.
- **GPT-5.5: Pass.** The memo explicitly links the Reedley/Mitchum internal engineering emails to punitive damages exposure, stating they show knowledge of the risk, prediction of a crush amputation, rejection/deferral of a low-cost fix for budget/delivery reasons, and that this evidence makes punitive damages likely to be submitted to the jury. It specifically cites R.C. 2315.21 and frames the issue as 'flagrant or conscious disregard' under Ohio law.

### C-006

References 7 prior field reports as compounding punitive risk ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L59))

- **Sonnet 4.6: Pass.** The memo explicitly references '7 re-cycle field reports (2017--Feb. 2023), 3 with injuries' in the Case Snapshot section (Section II). Furthermore, in Section V (Punitive Damages), the memo states 'By October 2019, Greenfield already knew of all three injury reports (the emails list the 2018 laceration, the 2018 bruised hand, and the 2019 fractured wrist). Mitchum deferred the fix anyway.' The 7 prior field reports are directly tied to the punitive damages analysis and the notice/knowledge argument, satisfying the criterion.
- **GPT-5.5: Pass.** The memo expressly states under “Prior notice” that there were “7 re-cycle field reports (2017--Feb. 2023), 3 with injuries,” and uses those reports/emails in the liability and punitive-risk discussion to show Greenfield’s notice and conscious disregard exposure.

### C-007

Factors punitive damages into settlement range despite Ohio cap ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L67))

- **Sonnet 4.6: Pass.** The memo extensively analyzes punitive damages throughout multiple sections. In Section V, it discusses the likelihood of punitive damages submission and award, explicitly cites R.C. 2315.21(D)(2)(a) for the 2× compensatory cap, notes that punitive damages are uninsured under Ohio law, and estimates a probability-weighted punitive exposure of approximately $1.02M expected value with realistic adverse scenarios of $5M–$13M. The probability-weighted valuation table in Section VI includes punitive damages as a separate column. The memo also discusses the cap in relation to Greenfield's compensatory allocation, noting that a lower fault allocation shrinks punitive exposure. The analysis clearly factors punitive damages into the settlement range recommendation of $4.25M–$5.25M and the all-in risk-adjusted value of ~$4.4M, while acknowledging the Ohio statutory cap but recognizing the significant uninsured exposure it still creates.
- **GPT-5.5: Pass.** The memo explicitly analyzes punitive damages, estimates their likelihood and expected value, states that Ohio caps punitive damages at 2× compensatory damages under R.C. 2315.21(D)(2)(a), notes they are uninsured, and incorporates roughly $1.0M expected punitive exposure plus adverse-case punitive scenarios into the settlement valuation and recommended range.

### C-008

Identifies Ohio non-economic damages cap under O.R.C. § 2315.18 ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L75))

- **Sonnet 4.6: Pass.** The memo explicitly references Ohio's non-economic damages cap under R.C. 2315.18 in multiple places. In Section I, it corrects the defense brief's argument that non-economic damages are capped at $350,000 under R.C. 2315.18. In Section IV.B, it discusses the cap in detail, noting the general cap applies to Jennifer Holt's consortium claim ('the greater of $250,000 or three times her economic loss, with a $350,000 maximum per plaintiff'). The memo clearly addresses Ohio's non-economic damages cap under O.R.C. § 2315.18, including both the general cap provisions and the exception for permanent and substantial physical deformity/loss of limb.
- **GPT-5.5: Pass.** The memo explicitly discusses Ohio’s non-economic damages cap under R.C. 2315.18, including the $350,000 cap argument, the statutory exception for permanent and substantial deformity/loss of limb, and the general cap formulation of the greater of $250,000 or three times economic loss up to $350,000 per plaintiff for the consortium claim.

### C-009

Identifies cap exception for amputation under O.R.C. § 2315.18(B)(3) ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L83))

- **Sonnet 4.6: Pass.** The memo explicitly identifies the O.R.C. § 2315.18(B)(3) exception in multiple places. In Section I, it states the defense brief's non-economic cap argument is 'wrong on these facts' and cites the statute's exception for 'permanent and substantial physical deformity, loss of use of a limb, or loss of a bodily organ system,' noting that a traumatic below-elbow amputation falls squarely within that exception. Section IV.B is titled 'Non-Economic Damages --- Uncapped for Mr. Holt' and reiterates this point. The memo clearly recognizes and applies the cap exception rather than applying the general cap.
- **GPT-5.5: Pass.** The memo expressly states that the defense brief's reliance on the general non-economic damages cap is wrong because R.C. 2315.18(B)(3) removes the cap for permanent and substantial physical deformity, loss of use of a limb, or loss of a bodily organ system, and specifically says Holt's traumatic below-elbow dominant-arm amputation falls within that exception. It later reiterates that Holt's non-economic damages are uncapped.

### C-010

Recognizes full non-economic damages claim is viable ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L91))

- **Sonnet 4.6: Pass.** The memo explicitly addresses the non-economic damages cap issue in Section I (corrections to current defense position) and Section IV.B. It states that the R.C. 2315.18(B)(3) exception applies because a traumatic below-elbow amputation of the dominant arm falls squarely within the 'permanent and substantial physical deformity, loss of use of a limb, or loss of a bodily organ system' exception. The memo concludes the cap does not apply and assesses a realistic jury range of $2.5M–$6.0M for non-economic damages, with a most likely figure of $4.0M. This uncapped non-economic damages figure is incorporated into the settlement valuation and the target range of $4.25M–$5.25M.
- **GPT-5.5: Pass.** The memo expressly states that the Ohio non-economic damages cap does not apply because the plaintiff suffered a traumatic dominant-arm amputation, identifies the statutory exception, values Marcus Holt’s non-economic damages at a realistic uncapped range of $2.5M–$6.0M with $4.0M most likely, and incorporates that into the gross verdict and settlement valuation.

### C-011

Addresses workers' comp subrogation lien amount ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L99))

- **Sonnet 4.6: Pass.** The memo explicitly identifies the Buckeye Mutual workers' compensation subrogation lien as $481,800 ($418,600 medical + $63,200 TTD) in the Case Snapshot section. It also discusses the lien's impact on settlement in multiple places: Section VII analyzes how the lien affects Plaintiffs' net recovery at various settlement amounts, discusses lien compromise under R.C. 4123.931, and Section VIII.D addresses lien satisfaction and indemnity as deal terms. The memo also flags a record anomaly where billed past medical ($363,700) is less than workers' comp medical paid ($418,600) and recommends obtaining Buckeye's itemized ledger.
- **GPT-5.5: Pass.** The memo expressly identifies the Buckeye Mutual workers' compensation subrogation lien as $481,800, broken down into $418,600 medical and $63,200 TTD. It also discusses the lien’s settlement impact, including net recovery calculations, potential compromise under R.C. 4123.931, lien ledger issues, and lien satisfaction/indemnity as deal terms.

### C-012

Analyzes lien's impact on plaintiff's net recovery and settlement dynamics ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L107))

- **Sonnet 4.6: Pass.** Section VII of the memo explicitly analyzes the lien's impact on plaintiff's net recovery. It includes a table showing gross settlement amounts with deductions for the one-third contingency fee and the $481,800 lien, calculating net recovery to the Holts at various settlement levels. It also notes that the lien is subject to the statutory allocation formula and is 'routinely compromised,' and that a lien reduction 'increases Plaintiffs' net recovery at no cost to Greenfield.' The memo further discusses using lien compromise as a bridging tool in negotiations (Section VIII.D), noting Greenfield should encourage direct negotiation between plaintiffs' counsel and Buckeye on the lien. This clearly goes beyond merely listing the lien amount—it analyzes how the lien affects plaintiff's net recovery and how that dynamic can be leveraged in settlement negotiations.
- **GPT-5.5: Pass.** The memo expressly analyzes the $481,800 workers’ compensation subrogation lien’s effect on plaintiffs’ net recovery, including a table showing gross settlement minus fees and lien, and discusses how lien compromise can increase plaintiffs’ net and affect settlement floor/dynamics.

### C-013

Analyzes Apex's guard modification as comparative fault factor ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L115))

- **Sonnet 4.6: Pass.** The memo extensively discusses Apex's unauthorized guard modification as a comparative fault factor. Section III.B ('Causation and the Apex Modification') details how Briggs removed the OEM fixed guard (1" gap, interlocked) and replaced it with a ShieldTech guard (4.5" gap, not interlocked) for production convenience, without contacting Greenfield or ShieldTech. The comparative fault table in Section III.C explicitly allocates 25-50% fault to Apex as a non-party. The memo also discusses the R.C. 2307.23 non-party allocation defense and the implications of the 50% threshold under R.C. 2307.22. This clearly satisfies the criterion.
- **GPT-5.5: Pass.** The memo explicitly discusses Apex/Briggs replacing the OEM 1-inch-gap interlocked guard with a ShieldTech guard with a 4.5-inch gap, characterizes the guard swap as a key causation issue, and uses it to support allocation of fault to Apex in a comparative fault table and related analysis.

### C-014

Recognizes re-cycling defect exists independently of guard modification ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L123))

- **Sonnet 4.6: Pass.** The memo explicitly addresses the independence of the re-cycling defect from the guard modification in Section III.B. It notes the 'Unanswered workflow question' where Kwan says the 1" OEM gap blocked hand entry 'during all phases of the press cycle,' but then acknowledges that Vasquez says the guard was built to allow retrieval, implying the OEM guard may not have fully protected against the hazard. More directly, the memo references the Vasquez opinion on 'hazard even with OEM guard' as a key factor in the Daubert motion analysis, stating 'If Greenfield wins the Daubert motion in full... the expected value would fall.' This implicitly acknowledges that Vasquez's opinion—that the defect created a hazard even with the original guard—is a live issue. The memo also notes that the design defect (single-point-of-failure hydraulic interlock, valve V-101) is the core plaintiff theory, and that the Reedley emails establish the defect existed before any guard modification. The memo does not treat the Apex modification as completely eliminating Greenfield's liability; rather, it consistently frames the modification as a comparative fault issue while maintaining that Greenfield's design defect is independently established. The reference to Vasquez's 'hazard even with OEM guard' opinion as a swing factor in the Daubert motion confirms the memo recognizes this independent defect argument.
- **GPT-5.5: Pass.** The memo expressly treats the re-cycling/single-valve design defect as an independent basis for liability, states that Apex’s guard swap is significant but “not a complete defense,” and references Dr. Vasquez’s opinion that there was a “hazard even with OEM guard.” It therefore does not treat the modification as eliminating Greenfield’s liability and acknowledges the independent defect theory, even if it does not fully spell out the downstroke/upstroke mechanics.

### C-015

Provides fault allocation percentage or range for Greenfield ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L131))

- **Sonnet 4.6: Pass.** The memo explicitly provides fault allocation percentages for Greenfield in Section III.C, stating 'Our realistic trial range' for Greenfield is '40%--70% (most likely ≈ 55--65%)'. This falls within a reasonable zone of the 40%–60% benchmark specified in the criterion.
- **GPT-5.5: Pass.** The memo provides specific Greenfield fault allocation estimates, including a realistic trial range of 40%–70% with most likely 55%–65%, and also references an internal 40%–60% range.

### C-016

Provides fault allocation percentage or range for Apex ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L139))

- **Sonnet 4.6: Pass.** The memo includes a comparative fault allocation table in Section III.C that explicitly provides a range for Apex (non-party employer): 'Defense brief: 55%–70%', 'Comparables workbook (internal): 25%–45%', and 'Our realistic trial range: 25%–50%'. These figures are specific percentage ranges for Apex's fault allocation, satisfying the criterion.
- **GPT-5.5: Pass.** The memo includes a comparative fault allocation table specifically for Apex, listing an internal comparables range of 25%–45% and a realistic trial range of 25%–50%. This satisfies the requirement to provide a specific Apex fault allocation percentage or range within a reasonable zone.

### C-017

Provides fault allocation percentage or range for Holt ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L147))

- **Sonnet 4.6: Pass.** The memo explicitly provides a fault allocation range for Holt in Section III.C, listing '0%--10%' as the realistic trial range for Holt's comparative fault. This falls within a reasonable zone of the 5%–15% reference range mentioned in the criterion.
- **GPT-5.5: Pass.** The memo includes a comparative fault allocation table with specific percentages for Holt, including 5%–15% in the internal comparables and a realistic trial range of 0%–10%.

### C-018

References Ohio's modified comparative fault system ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L155))

- **Sonnet 4.6: Fail.** The memo discusses Ohio's comparative fault system extensively in Section III.C, including the 50% threshold under R.C. 2307.22 (joint and several liability when defendant is more than 50% at fault), several-only liability for non-economic damages, and the allocation to non-parties under R.C. 2307.23. However, the criterion specifically asks for reference to Ohio's modified comparative fault system under O.R.C. § 2315.33 or equivalent description, including that the plaintiff can recover as long as plaintiff's fault does not exceed 50%. The memo does not cite R.C. 2315.33 and does not explicitly state the rule that a plaintiff is barred from recovery if their fault exceeds 50%. The memo discusses Holt's fault allocation (0-10%) and the 50% threshold for joint and several liability against Greenfield, but never states the plaintiff-side bar. The criterion requires reference to the modified comparative fault framework including that plaintiff can recover as long as plaintiff's fault does not exceed 50%. The memo omits this plaintiff-side aspect of the modified comparative fault rule and does not cite § 2315.33. This is a fail.
- **GPT-5.5: Fail.** The memo discusses comparative fault allocation and Ohio joint-and-several liability thresholds for Greenfield under R.C. 2307.22/2307.23, but it does not reference Ohio’s modified comparative fault rule under R.C. 2315.33 or state that the plaintiff may recover so long as the plaintiff’s own fault does not exceed 50%.

### C-019

Applies fault allocated to non-party Apex as reducing plaintiff's recovery ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L163))

- **Sonnet 4.6: Pass.** The memo explicitly addresses how fault allocated to non-party Apex reduces plaintiff's recovery from Greenfield. In Section III.C, the memo discusses the comparative fault allocation table and explains the 50% threshold under R.C. 2307.22: if Greenfield is found at 50% or below, it pays only its proportionate share (several liability only), meaning Apex's allocated fault reduces what Greenfield owes. The probability-weighted valuation in Section VI applies this directly—in the '≤50%' scenario, Greenfield's compensatory exposure is calculated as 'several only' (~$2.5M based on ~40% allocation), explicitly showing that Apex's fault share reduces Greenfield's recovery obligation. The memo also notes that non-economic damages are 'several-only in either case.' This clearly applies the principle that fault allocated to non-party Apex reduces plaintiff's recovery from Greenfield.
- **GPT-5.5: Pass.** The memo expressly applies non-party Apex fault to reduce Greenfield’s liability in multiple places, including stating that if Greenfield is at 50% or below it pays only its proportionate share, non-economic damages are several-only, and modeling a reduced recovery in the Greenfield ≤50% scenario. It also notes Apex allocation reduces plaintiffs’ recovery in settlement analysis.

### C-020

Identifies litigation reserve of $3.2M as inadequate and recommends increase ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L171))

- **Sonnet 4.6: Pass.** Section IX of the memo explicitly states that the $3.2M reserve 'no longer reflects a probable, estimable loss' and recommends increasing it to at least $4.5M. The memo notes the reserve was set in Q2 2024 'before the emails, the field reports, and the expert discovery.' This directly satisfies the criterion of identifying the $3.2M reserve as inadequate and recommending an increase.
- **GPT-5.5: Pass.** The memo explicitly states that the $3.2M reserve, set in Q2 2024, no longer reflects the probable, estimable loss and recommends increasing it to at least $4.5M. It also ties the inadequacy to updated case risks including emails, field reports, expert discovery, settlement valuation, and punitive exposure.

### C-021

Recommends specific updated reserve amount ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L179))

- **Sonnet 4.6: Pass.** The memo explicitly recommends increasing the litigation reserve from $3.2M to 'at least $4.5M (gross)' in the Bottom Line table, and reiterates this in Section IX: 'We recommend increasing it to at least $4.5M, the low-to-mid point of the target range.' This is a specific figure ($4.5M) that is higher than the current $3.2M reserve and falls within the expected zone ($4M–$8.5M). The criterion is satisfied.
- **GPT-5.5: Pass.** The memo explicitly recommends increasing the litigation reserve from $3.2M to at least $4.5M, and this amount aligns with the recommended settlement range of $4.25M–$5.25M.

### C-022

Discusses post-incident interlock addition as litigation risk ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L187))

- **Sonnet 4.6: Pass.** The memo mentions ECO-2023-0047 (the fix that went into production September 1, 2023, about three months after Holt's June 18, 2023 injury) in the case snapshot under 'Prior notice.' However, the memo's treatment of this fact is limited to noting it as background context. The criterion requires that the memo analyze the trial risk this post-incident interlock addition creates as a litigation risk factor. The memo does briefly address Federal Rule of Evidence 407 (subsequent remedial measures) in Section III.A, noting that 'Under Fed. R. Evid. 407, the post-incident ECO is generally inadmissible to prove defect. But the 2019 emails are pre-incident and fully admissible, and they establish feasibility and cost on their own. If Greenfield disputes feasibility, or keeps describing the change as "routine continuous improvement" (as the defense brief does), it risks opening the door to the ECO for feasibility or impeachment.' This does discuss the post-incident design change (ECO-2023-0047, the redundant interlock addition) and analyzes the litigation risk it creates—specifically the risk that it could be admitted for feasibility or impeachment if Greenfield disputes feasibility. This satisfies the criterion of discussing the post-incident interlock addition as a litigation risk factor.
- **GPT-5.5: Pass.** The memo expressly notes that the fix was implemented in production on September 1, 2023 after Holt’s June 18, 2023 injury, references ECO-2023-0047, and analyzes the litigation risk under Fed. R. Evid. 407, including potential admissibility for feasibility or impeachment if Greenfield disputes feasibility or characterizes it as routine improvement. This satisfies the criterion.

### C-023

References FRE 407 and its exceptions regarding post-incident remedial measure ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L195))

- **Sonnet 4.6: Pass.** The memo explicitly references Fed. R. Evid. 407 in Section III.A: 'Under Fed. R. Evid. 407, the post-incident ECO is generally inadmissible to prove defect. But the 2019 emails are pre-incident and fully admissible, and they establish feasibility and cost on their own. If Greenfield disputes feasibility, or keeps describing the change as "routine continuous improvement" (as the defense brief does), it risks opening the door to the ECO for feasibility or impeachment.' This directly addresses FRE 407's general rule (subsequent remedial measures inadmissible to prove defect) and its exception (admissible to show feasibility if disputed), satisfying the criterion.
- **GPT-5.5: Pass.** The memo explicitly cites Fed. R. Evid. 407, states that the post-incident ECO is generally inadmissible to prove defect, and discusses exceptions/uses such as feasibility if disputed and impeachment/opening the door.

### C-024

Identifies Daubert risk to defense expert Dr. Kwan ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L203))

- **Sonnet 4.6: Pass.** The memo explicitly discusses Daubert risk to defense expert Dr. Kwan in Section III.A, noting that 'Dr. Kwan does not analyze the valve failure, the field reports, or the emails, even though he lists them as materials reviewed. That leaves him open to a "no root-cause analysis" attack, and possibly to a Daubert challenge by Plaintiffs.' Additionally, Section III.B references the Daubert motion regarding Vasquez but also notes in the context of Kwan's misquotation of Briggs that 'Kwan will be impeached on it.' The memo clearly identifies the risk that Kwan's testimony could face a Daubert challenge from Plaintiffs.
- **GPT-5.5: Pass.** The memo expressly discusses Dr. Kwan as the defense engineering expert and states that gaps in his analysis leave him open to a Daubert challenge by Plaintiffs, thereby identifying Daubert risk to the defense expert.

### C-025

Identifies analytical gap in Dr. Kwan's opinion regarding independent re-cycling defect ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L211))

- **Sonnet 4.6: Pass.** The memo discusses Dr. Kwan's analytical gaps in Section III.A and III.B. In Section III.A, it notes that 'Dr. Kwan does not analyze the valve failure, the field reports, or the emails, even though he lists them as materials reviewed. That leaves him open to a "no root-cause analysis" attack.' The valve failure (V-101/HV-7500-DC04) is the re-cycling defect — the single-point-of-failure hydraulic interlock that caused the ram to re-descend. The memo identifies that Kwan failed to analyze this valve failure (the independent re-cycling defect) while focusing on the Apex guard modification. However, the memo does not explicitly frame this as Kwan focusing on the guard modification as 'sole proximate cause' while ignoring the independent re-cycling defect as a separate theory. The memo does note Kwan's failure to analyze the valve failure and the field reports, which is the re-cycling defect issue, and separately discusses the causation fight around the Apex modification. The criterion asks whether the memo identifies that Kwan focuses on Apex's guard modification as sole proximate cause but does not adequately address the independent re-cycling defect. The memo does identify Kwan's failure to analyze the valve failure (re-cycling defect) and the field reports, which captures the analytical gap. The connection between Kwan's focus on the modification defense and his neglect of the re-cycling defect analysis is present, though not stated in those exact terms. This is sufficient to satisfy the criterion.
- **GPT-5.5: Pass.** The memo expressly identifies the gap in Dr. Kwan’s opinion, stating that he “does not analyze the valve failure, the field reports, or the emails” despite relying on Apex’s guard modification, and frames the guard-modification theory as the defense’s strongest issue but “not a complete defense.” This captures the specific analytical gap that Kwan focuses on the Apex modification/sole-cause theory without adequately addressing the independent re-cycling defect.

### C-026

Compares Dr. Aldrich's and Dr. Cho's economic damages figures ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L219))

- **Sonnet 4.6: Pass.** The memo explicitly compares both economists' figures in Section IV.A, presenting Dr. Aldrich's total of $2,405,400 and Dr. Cho's reported total of $1,687,200 side by side in a detailed table, along with line-by-line breakdowns of each component (past medical, past lost wages, future medical, future lost earning capacity, future fringe benefits). The memo also discusses the differences between the two figures and provides a corrected Cho figure and a 'likely jury figure' column.
- **GPT-5.5: Pass.** The memo includes a dedicated economic damages table comparing Aldrich's plaintiff-side total of $2,405,400 with Cho's defense-side reported total of $1,687,200, and discusses the differences and corrections.

### C-027

Identifies specific disputed assumptions between economists ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L227))

- **Sonnet 4.6: Pass.** The memo identifies the following disputed assumptions between Dr. Aldrich and Dr. Cho: (1) discount rate: '2.5% vs. 3.5%' explicitly mentioned; (2) residual/alternative earnings: '$42K vs. $52K' explicitly mentioned; (3) work-life expectancy: '27 vs. 24 years' explicitly mentioned; (4) prosthetics: mentioned as a disagreement worth 'about $176,000 undiscounted' but does not specify the unit cost or replacement cycle figures ($85,000×8 vs. $72,000×7). Three of the four specific disputed assumptions are clearly identified with the exact figures from the criterion. The fourth (prosthetic costs) is mentioned as a disputed item but without the specific unit/cycle breakdown. Since the criterion requires at least 3 of 4, and the memo clearly identifies 3 (discount rate, alternative wage, work-life expectancy), this is a PASS.
- **GPT-5.5: Pass.** The memo expressly identifies at least three disputed economist assumptions: discount rate (2.5% vs. 3.5%), residual/alternative earnings ($42K vs. $52K), and work-life expectancy (27 vs. 24 years). It also discusses prosthetics, though not with the exact $85,000×8 vs. $72,000×7 figures. Because at least 3 of the 4 required assumptions are identified, it satisfies the criterion.

### C-028

Analyzes which economic assumptions are more defensible ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L235))

- **Sonnet 4.6: Pass.** The memo does not simply average the two economic totals. In Section IV.A, it analyzes each disputed assumption individually: (1) Discount rate — it finds Cho's 3.5% better supported by current Treasury/TIPS yields and a 2024 practitioner survey, and notes Aldrich's own report undermines the 2.2–2.8% figure; (2) Residual earnings — it finds Cho has stronger evidence (CRC vocational assessment) but notes a jury may discount the $52K figure due to visible disability and psychiatric diagnosis; (3) Work-life expectancy — it finds Aldrich's reasoning 'intuitively stronger' because ironworker attrition tables fit poorly for someone who can no longer work as an ironworker; (4) Prosthetics — it finds Cho's initial-fitting vs. replacement distinction 'sound' and treats it as roughly a split. The memo then arrives at its own 'likely jury figure' column that reflects these judgments rather than a mechanical average. This constitutes genuine analysis of which assumptions are more defensible.
- **GPT-5.5: Pass.** The memo expressly evaluates the competing economic assumptions rather than merely averaging totals. It discusses discount rate, residual earnings, work-life expectancy, and prosthetics, identifying which side’s assumptions are stronger or more defensible and why, then estimates a likely jury figure.

### C-029

Arrives at a 'most probable' economic damages figure ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L243))

- **Sonnet 4.6: Pass.** The memo provides a 'most probable' economic damages figure of approximately $2.1M in the damages table under Section IV.A, which falls between Dr. Aldrich's $2,405,400 and Dr. Cho's $1,687,200, and squarely within the $1,900,000–$2,200,000 midpoint range. The memo also provides reasoning for the adopted assumptions: it discusses the discount rate dispute (favoring Cho's 3.5% as better supported), residual earnings (Cho has stronger evidence but with caveats), work-life expectancy (Aldrich's reasoning is intuitively stronger), and prosthetics (roughly a split). The corrected Cho figure of ~$1.81M is also provided. The synthesized 'likely jury figure' of ~$2.1M is explicitly used in the probability-weighted valuation in Section VI.
- **GPT-5.5: Pass.** The memo provides a synthesized “Our likely jury figure” for economic damages of approximately $2.1M, which falls between Dr. Aldrich’s $2,405,400 and Dr. Cho’s $1,687,200 and within the criterion’s approximate $1.9M–$2.2M range. It also explains the assumptions behind the midpoint, including discount rate, residual earnings, work-life, prosthetics, and the correction to Dr. Cho’s omitted fringe benefits.

### C-030

Addresses Halcyon contract as practical settlement pressure ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L251))

- **Sonnet 4.6: Pass.** The memo does mention the Halcyon contract multiple times. In Section I (Bottom Line), it states 'a public trial built around the internal emails is the main threat to the Halcyon contract' and notes this factor 'stays inside this memo and must not be mentioned in mediation.' In Section VIII.D (Tactics and Guardrails), it instructs to 'Say nothing, directly or indirectly, about the Halcyon contract, the Board's timing preference, or reputational concerns.' In Section XI, it directs the Committee to 'confirm the confidentiality protocol regarding Halcyon.' However, the criterion specifically requires that the memo identify the pending $60M equipment supply contract with Halcyon Construction Group and discuss how the Board's desire to avoid adverse trial publicity to protect this contract creates practical pressure to settle, potentially at the higher end of the reasonable range. The memo mentions Halcyon as a reputational/publicity concern and notes it as a settlement pressure factor, but it does not specify the $60M contract value. Despite the missing dollar figure, the memo does identify Halcyon as a business motivation to settle before trial and discusses how trial publicity threatens this contract relationship, which satisfies the core of the criterion even without the specific dollar amount.
- **GPT-5.5: Pass.** The memo repeatedly mentions the Halcyon contract, identifies adverse trial publicity from the internal emails as a key business risk, states that this factor supports settlement above pure expected value, and instructs that the Halcyon/reputational pressure not be disclosed in mediation. Although it does not state the $60M amount or full Halcyon Construction Group name, it addresses the practical settlement pressure contemplated by the criterion.

### C-031

Identifies loss of consortium as separate damages element ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L259))

- **Sonnet 4.6: Pass.** The memo explicitly addresses Jennifer Holt's loss of consortium claim as a separate damages element in Section IV.B ('Non-Economic Damages'). It identifies it as 'her own claim,' discusses the applicable cap (R.C. 2315.18), and quantifies it at '$100,000–$350,000, most likely $250,000.' It is also included as a separate line item in the gross compensatory verdict range table in Section IV.C, with values of $0.15M (defense-favorable), $0.25M (most likely), and $0.35M (plaintiff-favorable). This clearly satisfies the criterion of identifying the loss of consortium claim as a separate derivative claim with specific quantification within a reasonable range.
- **GPT-5.5: Pass.** The memo separately identifies Jennifer Holt’s loss of consortium claim, discusses its cap treatment, and assigns it an independent value of $100,000–$350,000, most likely $250,000, which is included as a separate damages component in the valuation tables.

### C-032

Analyzes loss of consortium under Ohio law ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L267))

- **Sonnet 4.6: Fail.** The memo mentions Jennifer Holt's consortium claim and discusses the cap issue (whether the general non-economic cap applies to her claim versus the R.C. 2315.18(B)(3) exception), and values the claim at $100,000–$350,000. However, the criterion specifically requires analysis of whether comparative fault reduction applicable to Marcus Holt also applies to Jennifer Holt's derivative consortium claim, or whether consortium damages are subject to separate fault allocation under Ohio law. The memo does not address this derivative/fault-allocation question at all. It only addresses the cap question, not the comparative fault/derivative nature of the consortium claim under Ohio law. This falls short of the criterion's requirements.
- **GPT-5.5: Fail.** The memo does discuss Jennifer Holt’s consortium claim beyond a mere line item, including a brief Ohio damages-cap analysis. However, it does not analyze whether Marcus Holt’s comparative fault reduction applies to Jennifer’s derivative loss-of-consortium claim or whether consortium damages require a separate fault allocation under Ohio law. The criterion specifically requires that treatment.

### C-033

Identifies potential contribution/indemnity claim against Apex ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L275))

- **Sonnet 4.6: Pass.** The memo explicitly addresses contribution against Apex in Section III.C: 'The defense brief "reserves" contribution against Apex under R.C. 2307.25. Workers\'compensation immunity generally bars contribution claims against a complying employer unless there is a contractual indemnity. We have seen no indemnity provision in the Apex purchase documents. The Committee should not count on any recovery from Apex, and the brief should not imply that recovery is available.' This directly identifies the potential contribution claim under Ohio's contribution statute (R.C. 2307.25) and factors it into the analysis by advising the Committee not to rely on it, which is the relevant net cost consideration.
- **GPT-5.5: Pass.** The memo expressly discusses a potential contribution claim against Apex under R.C. 2307.25 and possible contractual indemnity, while concluding workers’ compensation immunity likely bars recovery absent an indemnity provision and advising the Committee not to count on any offset. This identifies and factors the issue into the net-cost analysis, even though it discounts the claim’s value.

### C-034

Notes settlement does not extinguish contribution rights against Apex ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L283))

- **Sonnet 4.6: Fail.** The memo discusses contribution rights against Apex in Section III.C, but it focuses on whether contribution is available at all (concluding it is unlikely due to workers' compensation immunity and lack of contractual indemnity). The memo does not address how settlement with the plaintiff affects Greenfield's contribution rights against Apex — i.e., it does not note that settling with the plaintiff does not necessarily extinguish any contribution claim against Apex. The memo's treatment of contribution is limited to advising the Committee not to count on recovery from Apex and to correct the brief's implication that contribution is available, without analyzing the interaction between settlement and contribution rights.
- **GPT-5.5: Fail.** The memo discusses contribution from Apex generally, stating it is unlikely due to workers’ compensation immunity absent contractual indemnity. However, it does not address the specific interaction between settling with the plaintiff and Greenfield’s potential contribution rights, nor does it note that settlement does not necessarily extinguish such rights. Therefore it does not satisfy the criterion.

### C-035

Identifies Garza v. Titan Hydraulics as most analogous comparable ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L291))

- **Sonnet 4.6: Pass.** The memo explicitly identifies Garza v. Titan Hydraulics (S.D. Ohio 2020) as the 'Most analogous' comparable case in the comparables table, noting it involved the same injury type (below-elbow amputation), same district (S.D. Ohio), employer modification (20%), and admitted defect, with a $6.4M settlement. The memo also uses Garza as the primary reference point in the adjusted indication column and references it again in the narrative summary of comparables, stating it 'supports a settlement zone of about $4M--$6.5M.' This clearly satisfies the criterion.
- **GPT-5.5: Pass.** The memo expressly identifies Garza v. Titan Hydraulics (S.D. Ohio 2020) as the “Most analogous” comparable, lists the $6.4M settlement, and explains the analogy based on same injury, same district/jurisdiction, employer modification at 20%, and admitted defect.

### C-036

Identifies Novak v. Steelform Industries as most analogous comparable ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L299))

- **Sonnet 4.6: Fail.** The memo does reference Novak v. Steelform in the comparables table (Section VI) with the $8.7M verdict and estimated $6.5M–$7.5M on appeal, noting 'Prior notice; above-elbow (more severe)' as relevance. However, the criterion requires that Novak be identified as 'one of the most analogous comparable cases' with explanation of why (prior notice, similar injury severity, Ohio jurisdiction). The memo actually identifies Garza v. Titan Hydraulics as 'Most analogous: same injury and district, employer modification (20%); defect admitted,' while Novak is listed second with less emphasis. The memo does not characterize Novak as particularly analogous — in fact it explicitly labels Garza as the most analogous. Novak is mentioned but not identified as one of the most analogous comparables as the criterion requires.
- **GPT-5.5: Pass.** The memo includes Novak v. Steelform in the comparable outcomes table, identifies it as an N.D. Ohio 2022 case with an $8.7M verdict / estimated $6.5M–$7.5M appeal value, and explains its relevance based on prior notice and an above-elbow amputation, i.e., similar severe injury in Ohio. Although it labels Garza as the single 'Most analogous,' it still treats Novak as a significant analogous comparable and gives the required rationale.

### C-037

Discusses adjustments to comparables for factual differences ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L307))

- **Sonnet 4.6: Pass.** The memo includes a comparables table in Section VI that explicitly discusses factual differences and their impact on applicability. For Garza, it notes 'same injury and district, employer modification (20%); defect admitted' and adjusts to '$5.0M–$6.5M before discount for higher Apex share / contested defect.' For Novak, it notes 'Prior notice; above-elbow (more severe)' and adjusts downward. For Tanaka, it notes 'Expert-exclusion risk' and adjusts accordingly. For Williams, it notes 'Less severe; plaintiff bypassed guard.' For Ostrowski, it notes 'Partial hand; plaintiff removed guard' and labels it 'Low relevance.' For Brewer, it explains the modification defense won 'on weaker facts for the plaintiff.' For Petersen, it notes 'Bilateral injury' and labels it a 'Ceiling reference only.' The narrative following the table also synthesizes these adjustments, noting the comparables support '$4M–$6.5M' and that the target sits in the lower half 'which reflects the genuinely contested causation defense and the Apex modification that Garza and Novak did not have to the same degree.' This clearly satisfies the criterion of explaining adjustments to comparables for factual differences.
- **GPT-5.5: Pass.** The memo does more than list comparables: it expressly analyzes factual differences and adjusts their relevance/value indications, including Garza’s admitted defect versus Holt’s contested defect and higher Apex share, Novak’s more severe above-elbow amputation, Williams/Ostrowski plaintiff or employer guard issues, Brewer’s lack of notice/internal documents/non-amputation, and Petersen’s bilateral injury as a ceiling reference. It also ties the final settlement zone to these adjustments.

### C-038

Provides settlement range with low/mid/high values ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L315))

- **Sonnet 4.6: Pass.** The memo provides a tiered settlement structure. In Section I (Bottom Line), it states a target settlement range of $4.25M–$5.25M, recommended authority up to $5.5M, and a pre-cleared path to $6.0M via mediator's proposal. In Section IV.C, it explicitly provides three scenarios: Defense-favorable (~$4.5M gross compensatory), Most likely (~$6.35M), and Plaintiff-favorable (~$8.75M). The concession path in Section VIII.C also shows a structured progression. The memo clearly differentiates low, mid, and high estimates across multiple sections, satisfying the criterion for a tiered structure.
- **GPT-5.5: Pass.** The memo provides more than a single point or undifferentiated range: it gives a target settlement range ($4.25M–$5.25M), recommended authority up to $5.5M, a mediator-proposal ceiling of $6.0M, and tiered settlement/negotiation figures including expected close values. This is an equivalent tiered structure with low/mid/high settlement guidance.

### C-039

Settlement range falls within reasonable bounds ($4M–$8.5M) ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L323))

- **Sonnet 4.6: Pass.** The agent recommends a target settlement range of $4.25M–$5.25M, with mediation authority up to $5.5M and a pre-cleared path to $6.0M via mediator's proposal. The low end ($4.25M) is above the $3.5M floor, and the high end ($5.25M, or $6.0M with mediator's proposal) is well below the $9.5M ceiling. The midpoint of the primary target range is approximately $4.75M, which is slightly below the ideal $5M–$7M midpoint range specified in the criterion. However, the criterion states the midpoint should fall 'approximately between $5M and $7M,' and $4.75M is close to $5M. The authorized ceiling of $5.5M–$6.0M brings the effective midpoint closer to $5M–$5.5M. The range is not 'dramatically outside' the bounds—the low end is not below $2M and the high end is not above $12M. The criterion says FAIL only if 'dramatically outside these bounds.' The recommended range of $4.25M–$5.25M (with authority to $6M) is within reasonable bounds overall, though the midpoint is at the lower edge of the ideal range. This does not constitute a dramatic failure of the criterion.
- **GPT-5.5: Pass.** The memo recommends a target settlement range of $4.25M–$5.25M, with authority up to $5.5M and possible mediator proposal up to $6.0M. The low end is above the approximate $3.5M floor, the high end is well below the $9.5M ceiling, and the midpoint of $4.75M is close to the approximately $5M lower bound for an acceptable midpoint. This is within reasonable bounds under the criterion.

### C-040

Provides recommended opening offer for mediation ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L331))

- **Sonnet 4.6: Pass.** The memo explicitly provides a recommended opening offer in Section VIII.B: '$1.5M if the brief is revised to delete its numeric range, or at $1.8M if the brief is served as drafted.' It also provides detailed strategic rationale explaining why not to go higher (midpoint dynamics, symmetric midpoint of ~$5.5M-$5.65M) and why not to go lower (risk of stalled session, bad faith perception, prejudgment interest risk). Additionally, Section VIII.C provides a full planned concession path with round-by-round moves and messaging. The criterion is clearly satisfied.
- **GPT-5.5: Pass.** The memo includes a specific recommended opening offer for the March 14, 2025 mediation: $1.5M if the defense brief is revised, or $1.8M if served with its current range. It also provides strategic rationale, including credibility concerns, midpoint dynamics, avoiding bad faith/prejudgment-interest risk, and a planned concession path and negotiation strategy.

### C-041

Assesses insurance coverage adequacy ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L339))

- **Sonnet 4.6: Pass.** The memo explicitly discusses the insurance tower: it identifies Ridgeline primary at $10M per occurrence (defense costs outside limits, SIR exhausted, no reservation of rights on compensatory damages) and Beacon $25M follow-form excess, totaling $35M. It notes that the recommended settlement range ($4.25M–$5.25M, with authority up to $5.5M and a mediator's proposal path to $6.0M) falls within the Ridgeline primary layer, meaning it costs the Company nothing out of pocket. It also assesses coverage adequacy by pointing out that both layers exclude punitive damages, making punitive exposure uninsured and a key driver for settlement. The memo explicitly states that 'a settlement inside the $10M Ridgeline primary layer costs the Company nothing out of pocket' and that 'Plaintiffs' brief frames the demand as being within the $35M tower, which obscures the fact that the tower does not cover the exposure that matters most to the Company.' This directly addresses insurance coverage adequacy in relation to the recommended settlement amount.
- **GPT-5.5: Pass.** The memo expressly identifies the insurance tower as Ridgeline primary $10M plus Beacon $25M follow-form excess, for $35M total, notes punitive exclusions, and explains that the recommended $4.25M–$5.25M settlement / $5.5M authority would fall within the $10M primary layer with the SIR exhausted, costing the company no out-of-pocket amount for covered compensatory settlement.

### C-042

Notes settlement likely within primary policy limits ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L347))

- **Sonnet 4.6: Pass.** The memo explicitly states in Section I that 'a settlement inside the $10M Ridgeline primary layer costs the Company nothing out of pocket, because the $250,000 SIR is already exhausted.' The target settlement range of $4.25M–$5.25M (with authority up to $6.0M) clearly falls within the $10M primary Ridgeline policy. The memo also notes that Plaintiffs' demand is framed as being 'within' the $35M tower but clarifies that the tower doesn't cover punitive damages. The memo implies the excess/umbrella (Beacon $25M follow-form) would not be triggered at settlement since the settlement range is well below the $10M primary limit. The memo also discusses that at trial, with adverse punitive scenarios, exposure could reach $13M–$20M, implying the umbrella could potentially be implicated at trial but not at settlement. This satisfies the criterion.
- **GPT-5.5: Pass.** The memo identifies a $10M Ridgeline primary policy and a $25M Beacon excess layer, recommends a settlement target of $4.25M–$5.25M with authority up to $5.5M/$6.0M, and expressly states that a settlement inside the $10M primary layer would cost the company nothing out of pocket. This clearly places the likely settlement within the primary policy limits and implies the excess/umbrella layer is unlikely to be reached in settlement, while noting larger trial exposure could exceed that range.

### C-043

References plaintiff's settlement demand of $9.5M ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L355))

- **Sonnet 4.6: Pass.** The memo explicitly references the plaintiff's $9.5 million demand in Section I ('considerably less than Plaintiffs' $9.5 million demand') and again in Section VIII.B ('Plaintiffs opened at an inflated $9.5M'). This satisfies the criterion.
- **GPT-5.5: Pass.** The memo explicitly references Plaintiffs' $9.5 million demand in the Bottom Line and later uses it as settlement context in the negotiation strategy.

### C-044

References defense's proposed range of $1.8M–$2.5M ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L363))

- **Sonnet 4.6: Pass.** The memo explicitly references the defense mediation brief's $1.8M–$2.5M range in multiple places. For example, in Section I it states 'the defense mediation brief argues...the brief's entire $1.8M–$2.5M valuation depends on the cap.' In Section VIII.A it mentions 'Consider deleting the numeric "$1.8M–$2.5M" range, which unnecessarily fixes our opening number in writing.' In Section VIII.B it states 'An opening below the brief's own floor would look like bad faith' in context of the $1.8M figure. The range is clearly referenced.
- **GPT-5.5: Pass.** The memo explicitly references the defense mediation brief's proposed range of $1.8M–$2.5M multiple times, including in the Bottom Line and negotiation strategy sections.

### C-045

Correctly states plaintiff's total economic damages per Dr. Aldrich ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L371))

- **Sonnet 4.6: Pass.** The memo's damages table in Section IV.A shows Dr. Aldrich's total as $2,405,400, which matches the criterion exactly. The table lists Aldrich's figures as: Past medical $363,700, Past lost wages $138,400, Future medical $814,300, Future lost earning capacity $892,600, Future fringe benefits $196,400, totaling $2,405,400.
- **GPT-5.5: Pass.** The memo’s Economic Damages table lists Dr. Aldrich’s total as $2,405,400, which exactly matches the required figure.

### C-046

Correctly states defense total economic damages per Dr. Cho ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L379))

- **Sonnet 4.6: Pass.** The memo explicitly states Dr. Cho's total as $1,687,200 in the damages table under Section IV.A, labeled as 'Cho (Def.) as reported'. This matches the criterion exactly.
- **GPT-5.5: Pass.** The memo explicitly states Dr. Cho’s reported defense total economic damages as $1,687,200, including in the economic damages table. Although it also discusses a corrected figure, it correctly identifies Cho’s stated total.

### C-047

References June 9, 2025 trial date as relevant timing factor ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L387))

- **Sonnet 4.6: Pass.** The memo explicitly references the trial date of June 9, 2025 in the header/RE line: 'Trial: June 9, 2025.' Additionally, the memo discusses the proximity of trial as a factor in settlement urgency throughout, including in Section I ('Why settle now') and in the negotiation strategy sections. The trial date is used as context for the mediation timing (March 14, 2025) and the overall recommendation to settle before trial.
- **GPT-5.5: Pass.** The memo expressly lists “Trial: June 9, 2025” in the header and frames the memo around pre-mediation timing, settlement authority, and costs/risks through trial, supporting trial timing as part of the settlement context.

### C-048

Discusses plaintiff's counsel's track record as risk factor ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L395))

- **Sonnet 4.6: Pass.** The memo mentions Calloway by name in Section VII, noting she 'won Petersen' and will 'threaten trial.' It also references the Petersen v. Ironhorse case ($14.2M → $11.8M) in the comparables table as a 'ceiling reference only' with 'Calloway was trial counsel.' The memo explicitly states 'Calloway won Petersen and will threaten trial' as a factor in assessing plaintiffs' settlement floor and trial risk. This satisfies the criterion of identifying plaintiff's counsel's track record as a risk factor that increases trial risk and settlement value.
- **GPT-5.5: Pass.** The memo specifically notes that Calloway won the Petersen case and will threaten trial, and the comparables table identifies Petersen v. Ironhorse as a $14.2M verdict with Calloway as trial counsel. This treats plaintiff counsel’s large-verdict track record as relevant to trial/settlement risk, satisfying the criterion.

### C-049

Correctly describes Holt's injury as below-elbow amputation ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L403))

- **Sonnet 4.6: Pass.** The memo in Section II (Case Snapshot) describes the injury as: 'Crush injury on June 18, 2023 → through-wrist amputation, then revision to trans-radial (below-elbow) amputation of the left (dominant) arm.' This correctly describes the injury as a through-wrist amputation revised to a below-elbow (trans-radial) amputation of the left arm. The criterion is satisfied.
- **GPT-5.5: Pass.** The memo correctly states that Holt sustained a through-wrist amputation that was revised to a trans-radial (below-elbow) amputation of the left dominant arm.

### C-050

Addresses Brewer defense verdict as limiting comparable ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L411))

- **Sonnet 4.6: Pass.** The memo explicitly discusses Brewer v. Atlas in multiple places. In Section III.B, it states 'The defense brief rests heavily on Brewer. The comparables analysis shows Brewer had no evidence of prior notice, no internal documents, and no amputation.' In the comparables table in Section VI, Brewer is listed with the note 'Shows the modification defense can win, but on weaker facts for the plaintiff.' In Section VIII.B, it references 'the Brewer precedent' as a point to emphasize. The memo both acknowledges Brewer as supporting Greenfield's modification defense and distinguishes it on the basis that Brewer lacked prior notice, internal documents, and involved a non-amputation injury — all of which differ from the Holt facts.
- **GPT-5.5: Pass.** The memo expressly discusses Brewer v. Atlas as a defense verdict where the modification defense can win, cites it in the causation section, and distinguishes it from Holt based on lack of prior notice, internal documents, and amputation. It also explains how Brewer supports Greenfield’s position but is weaker factually for the plaintiff than Holt.

### C-051

Discusses SIR exhaustion by defense costs ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L419))

- **Sonnet 4.6: Pass.** The memo explicitly states in Section I (Bottom Line): 'a settlement inside the $10M Ridgeline primary layer costs the Company nothing out of pocket, because the $250,000 SIR is already exhausted.' This directly addresses SIR exhaustion by defense costs, confirming that the $250,000 self-insured retention has been exhausted, meaning Ridgeline is now fully responsible within the primary layer. The criterion is satisfied.
- **GPT-5.5: Pass.** The memo repeatedly notes that the $250,000 SIR is exhausted, states defense costs to date are about $387K, and explains that a settlement within the $10M primary layer would cost Greenfield nothing out of pocket because the SIR is already exhausted. This satisfies the requirement to discuss SIR exhaustion by defense costs and resulting insurer responsibility within limits.

### C-052

Holt's 78% whole-person permanent impairment rating referenced ([rubric](https://github.com/harveyai/harvey-labs/blob/1dd81403b2fbb60596f7aea3fcecafad7bf73143/tasks/litigation-dispute-resolution/assess-settlement-value-range/task.json#L427))

- **Sonnet 4.6: Fail.** The memo mentions '78% whole-person impairment' in the Case Snapshot section under the injury description: 'phantom-limb pain; adjustment disorder/PTSD symptoms; permanently unable to work as an ironworker' and '78% whole-person impairment.' However, the criterion specifically requires that the 78% impairment rating be referenced as attributed to Dr. Okonkwo using the AMA Guides, 6th Edition. The memo mentions the 78% figure but does not attribute it to Dr. Okonkwo or the AMA Guides, 6th Edition. Additionally, the criterion requires it be referenced as a factor supporting the severity of non-economic damages, but in the memo it appears only in the factual case snapshot, not explicitly linked to non-economic damages analysis. That said, the criterion says PASS if the memo 'references Holt's 78% whole-person permanent impairment rating (AMA Guides, 6th Edition, per Dr. Okonkwo) as a factor supporting the severity of non-economic damages.' The memo does mention the 78% rating but does not mention Dr. Okonkwo or the AMA Guides, 6th Edition. The criterion requires these specific attributions. Since the memo lacks the attribution to Dr. Okonkwo and AMA Guides 6th Edition, it does not fully satisfy the criterion as described.
- **GPT-5.5: Pass.** The memo expressly mentions Holt’s “78% whole-person impairment” in the Case Snapshot injury description, satisfying the requirement that the 78% impairment rating be referenced.
